Pulsed field ablation technology has been used to treat atrial fibrillation for the first time in the U.S.

A study published Feb. 25 in Circulation suggests wearables are useful for detecting CV abnormalities like atrial fibrillation, but there’s still a long way to go before they can be trusted for clinical management.

Medtronic and the FDA were both aware of battery and wire connection defects in a now-recalled heart failure pacemaker for over a year before patients developed serious side effects, according to a report published in JAMA Internal Medicine.

A recent analysis of FitBit data suggests there is no one “normal” resting heart rate for humans, with users’ average HR coming in at between 40 and 109 beats per minute, Discover Magazine reported.

Medtronic has received CE mark approval in the European Union for its Cobalt and Crome implantable cardioverter-defibrillators and cardiac resynchronization therapy-defibrillators.

A panel of experts from the Clinical Genome Resource are publicly disputing nine of 17 genes once thought to be linked to long QT syndrome.

Emergency phone operators in Victoria, Australia, may soon have access to AI that could alert them to callers in cardiac arrest, ZDNet reports.

The FDA has approved a Medtronic-run trial, PULSED AF, to evaluate the safety and efficacy of new tech that uses pulsed electric fields to treat AFib.